AllCells Releases New Line of Bioservices

EMERYVILLE, Calif., Jan. 3, 2013 /PRNewswire/ -- AllCells LLC, a leading provider of healthy & diseased hematopoietic tissues and related services to the global life science industry is proud to announce the release of a new line of Bioservices. The CRO type of Bioservices will be focusing on drug discovery, preclinical research, drug toxicity assays, and other life science research applications.

Immunoassays

    --  ELISA (single, multiplex)
    --  ELISpot
    --  Cell Based Assays
    --  Luminex Assays (single, multiplex)

Stem Cell Assays

    --  Hematopoietic Stem Cell Based Assays
    --  Colony Forming Assays (CFU assays)
        --  CFU-M, CFU-GM, CFU-G, BFU-E
    --  Mesenchymal Stem Cell Based Assays
        --  CFU-F, osteoblast, chondrocyte and adipocyte differentiation

Flow Cytometry Services